176 related articles for article (PubMed ID: 34725559)
21. PDZK1-interacting protein 1 (PDZK1IP1) traps Smad4 protein and suppresses transforming growth factor-β (TGF-β) signaling.
Ikeno S; Nakano N; Sano K; Minowa T; Sato W; Akatsu R; Sakata N; Hanagata N; Fujii M; Itoh F; Itoh S
J Biol Chem; 2019 Mar; 294(13):4966-4980. PubMed ID: 30718277
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D
PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802
[TBL] [Abstract][Full Text] [Related]
23. TGF-beta signaling is dynamically regulated during the alveolarization of rodent and human lungs.
Alejandre-Alcázar MA; Michiels-Corsten M; Vicencio AG; Reiss I; Ryu J; de Krijger RR; Haddad GG; Tibboel D; Seeger W; Eickelberg O; Morty RE
Dev Dyn; 2008 Jan; 237(1):259-69. PubMed ID: 18095342
[TBL] [Abstract][Full Text] [Related]
24. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
Mu X; Lin S; Yang J; Chen C; Chen Y; Herzig MC; Washburn K; Halff GA; Walter CA; Sun B; Sun LZ
PLoS One; 2013; 8(5):e63436. PubMed ID: 23704908
[TBL] [Abstract][Full Text] [Related]
25. Multispectral imaging reveals hyper active TGF-β signaling in colorectal cancer.
Yang L; Liu Z; Tan J; Dong H; Zhang X
Cancer Biol Ther; 2018 Feb; 19(2):105-112. PubMed ID: 29219668
[TBL] [Abstract][Full Text] [Related]
26. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma.
Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z
Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237
[TBL] [Abstract][Full Text] [Related]
27. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
[TBL] [Abstract][Full Text] [Related]
28. SMAD4 feedback regulates the canonical TGF-β signaling pathway to control granulosa cell apoptosis.
Du X; Pan Z; Li Q; Liu H; Li Q
Cell Death Dis; 2018 Feb; 9(2):151. PubMed ID: 29396446
[TBL] [Abstract][Full Text] [Related]
29. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
30. 3-Phosphoinositide-dependent PDK1 negatively regulates transforming growth factor-beta-induced signaling in a kinase-dependent manner through physical interaction with Smad proteins.
Seong HA; Jung H; Kim KT; Ha H
J Biol Chem; 2007 Apr; 282(16):12272-89. PubMed ID: 17327236
[TBL] [Abstract][Full Text] [Related]
31. RAD51AP1 promotes progression of ovarian cancer via TGF-β/Smad signalling pathway.
Zhao H; Gao Y; Chen Q; Li J; Ren M; Zhao X; Yue W
J Cell Mol Med; 2021 Feb; 25(4):1927-1938. PubMed ID: 33314567
[TBL] [Abstract][Full Text] [Related]
32. Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors.
Olsen OE; Hella H; Elsaadi S; Jacobi C; Martinez-Hackert E; Holien T
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32235336
[TBL] [Abstract][Full Text] [Related]
33. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
[TBL] [Abstract][Full Text] [Related]
35. Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β).
Lin S; Yu L; Yang J; Liu Z; Karia B; Bishop AJR; Jackson J; Lozano G; Copland JA; Mu X; Sun B; Sun LZ
J Biol Chem; 2011 Dec; 286(51):44023-44034. PubMed ID: 22039050
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1.
Zhang H; Du L; Zhong Y; Flanders KC; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L615-L627. PubMed ID: 28642261
[TBL] [Abstract][Full Text] [Related]
37. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
[TBL] [Abstract][Full Text] [Related]
38. Regulation mechanisms of retinal pigment epithelial cell migration by the TGF-beta superfamily.
Mitsuhiro MR; Eguchi S; Yamashita H
Acta Ophthalmol Scand; 2003 Dec; 81(6):630-8. PubMed ID: 14641267
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of TGF-β1 and TGF-βR2 in tissue samples compared to blood is associated with food habits and survival in esophageal squamous cell carcinoma.
Talukdar J; Kataki K; Ali E; Choudhury BN; Baruah MN; Bhattacharyya M; Bhattacharjee S; Medhi S
Curr Probl Cancer; 2021 Feb; 45(1):100617. PubMed ID: 32660703
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.
Osawa H; Nakajima M; Kato H; Fukuchi M; Kuwano H
Anticancer Res; 2004; 24(6):3703-9. PubMed ID: 15736400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
